Bank of New York Mellon’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
+134,322
| New | +$364K | ﹤0.01% | 3675 |
|
|
2017
Q2 | – | Sell |
-171
| Closed | -$23K | – | 4308 |
|
|
2017
Q1 | $23K | Sell |
171
-4
| -2% | -$538 | ﹤0.01% | 4217 |
|
|
2016
Q4 | $27K | Sell |
175
-2
| -1% | -$309 | ﹤0.01% | 4190 |
|
|
2016
Q3 | $44K | Sell |
177
-59
| -25% | -$14.7K | ﹤0.01% | 4152 |
|
|
2016
Q2 | $211K | Buy |
236
+13
| +6% | +$11.6K | ﹤0.01% | 3881 |
|
|
2016
Q1 | $202K | Sell |
223
-3,528
| -94% | -$3.2M | ﹤0.01% | 3786 |
|
|
2015
Q4 | $5.3M | Sell |
3,751
-233
| -6% | -$329K | ﹤0.01% | 2177 |
|
|
2015
Q3 | $6.68M | Buy |
3,984
+2,369
| +147% | +$3.97M | ﹤0.01% | 2067 |
|
|
2015
Q2 | $3.48M | Buy |
1,615
+1,512
| +1,468% | +$3.26M | ﹤0.01% | 2572 |
|
|
2015
Q1 | $190K | Buy |
103
+11
| +12% | +$20.3K | ﹤0.01% | 3903 |
|
|
2014
Q4 | $220K | Buy |
+92
| New | +$220K | ﹤0.01% | 3861 |
|